Head Injuries, Closed: Clinical Trials

14 trials for Head Injuries, Closed, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 unknown, 3 recruiting, 2 not yet recruiting. 14 Phase 3, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 314Completed 4, Unknown 4, Recruiting 3, Not yet recruiting 2, Terminated 1
Phase 24Not yet recruiting 2, Recruiting 1, Unknown 1

Follow Head Injuries, Closed: new trials by email Literature Review of Head Injuries, Closed trials Research Report on Head Injuries, Closed

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion
ONE-D TMS protocol and d-cycloserine (125 mg) - Concussion, Depression
Phase 2 / Phase 3Not yet recruitingUniversity of Florida352026-09-012026-08-18
Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms
HRV Coherence Ratio, NSI, Pittsburgh Sleep Quality Index (PSQI) - Autonomic Nervous System Disease, Concussive Injury
Phase 2 / Phase 3RecruitingVirginia Commonwealth University1482025-09-022026-09-22
Memantine as an Additive Therapy in Patients With Traumatic Brain Injury
Memantine, Mannitol - Mild Traumatic Brain Injury, Moderate Traumatic Brain Injury (TBI)
Phase 2 / Phase 3Not yet recruitingMansoura University802025-03-252025-04-06
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
Somatropin, Placebo - Adult Growth Hormone Deficiency, Mild Traumatic Brain Injury
Phase 3RecruitingVA Office of Research and Development1722025-01-132026-10-13
Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)
Quetiapine Fumarate, TAU - Mild Traumatic Brain Injury
Phase 3RecruitingFoundation for Advancing Veterans' Health Research1462024-07-092025-07-11
Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury
Memantine Hydrochloride - Treatment of Cognitive Deficits After Traumatic Brain Injury
Phase 3CompletedAssiut University602024-01-012024-08-07
Interventions for Convergence Insufficiency in Concussed Children
Standard Community Concussion Care (SC), SC plus Simple Convergence Exercises (SC+), SC plus Office-based Vergence/Accommodative Therapy (SC+OBVAT) - Concussion, Convergence Insufficiency
Phase 3UnknownMitchell Scheiman2642021-04-012020-10-23
International Trial of Efficacy of Cytoflavin in Head Trauma
Cytoflavin ((Inosine + Nicotinamide + Riboflavin + Succinic Acid), Placebo - Head Trauma,Closed
Phase 3CompletedPOLYSAN Scientific & Technological Pharmaceutical Company1662020-11-222025-04-18
Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy
Somatropin - Traumatic Brain Injury, Fatigue
Phase 3CompletedThe University of Texas Medical Branch, Galveston722018-08-062025-03-05
Hyperbaric Oxygen Treatment to Treat Mild Traumatic Brain Injury (mTBI)/Persistent Post-Concussion Syndrome (PPCS)
Hyperbaric Oxygen, No Hyperbaric Oxygen - Post-Concussion Syndrome, Traumatic Brain Injury
Phase 3UnknownLouisiana State University Health Sciences Center in New Orleans592014-05-012017-04-18
Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinA
OnabotulinumtoxinA - Chronic Post Traumatic Headache
Phase 3TerminatedUniversity of Washington132014-05-012018-10-23
PLAY GAME: Post-concussion Syndrome in Youth - Assessing the GABAergic Effects of Melatonin
Melatonin, Sugar pill - Post-concussion Syndrome, Post-concussive Symptoms
Phase 2 / Phase 3UnknownUniversity of Calgary992013-09-012017-04-18
Study of Sand Versus Wood Chip Surfaces on School Playgrounds to Minimize Injury in School Children
school playgrounds - Wounds and Injuries, Closed Head Injury
Phase 3UnknownThe Hospital for Sick Children342005-01-012013-08-15
Magnesium Sulfate For Brain Injury
magnesium sulfate - Brain Injuries, Head Injury
Phase 3CompletedUniversity of Washington1998-08-012011-10-28

Narrower conditions

Brain Concussion (12)  ·  Brain Injuries, Traumatic (7)  ·  Post-Concussion Syndrome (3)  ·  Craniocerebral Trauma (2)  ·  Stress Disorders, Post-Traumatic (2)  ·  Brain Injuries (1)  ·  COVID-19 (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Dwarfism, Pituitary (1)  ·  Fatigue (1)  ·  Fractures, Bone (1)  ·  Ocular Motility Disorders (1)  ·  Wounds and Injuries (1)

Broader conditions

Nervous System Diseases (14)  ·  Trauma, Nervous System (14)  ·  Wounds, Nonpenetrating (14)  ·  Brain Diseases (13)  ·  Central Nervous System Diseases (13)  ·  Wounds and Injuries (13)  ·  Brain Injuries (12)  ·  Craniocerebral Trauma (12)  ·  Brain Injuries, Traumatic (6)  ·  Mental Disorders (3)  ·  Stress Disorders, Traumatic (2)  ·  Trauma and Stressor Related Disorders (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)

Interventions

Human Growth Hormone (2)  ·  Memantine (2)  ·  Botulinum Toxins, Type A (1)  ·  Hyperbaric Oxygenation (1)  ·  Inosine (1)  ·  Magnesium Sulfate (1)  ·  Mannitol (1)  ·  Melatonin (1)  ·  Niacinamide (1)  ·  Patient Health Questionnaire (1)  ·  Quetiapine Fumarate (1)  ·  Riboflavin (1)  ·  Succinic Acid (1)  ·  Sugars (1)  ·  Therapeutics (1)

Sponsors

University of Washington (2)  ·  Assiut University (1)  ·  Foundation for Advancing Veterans' Health Research (1)  ·  Louisiana State University Health Sciences Center in New Orleans (1)  ·  Mansoura University (1)  ·  Mitchell Scheiman (1)  ·  POLYSAN Scientific & Technological Pharmaceutical Company (1)  ·  The Hospital for Sick Children (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  University of Calgary (1)  ·  University of Florida (1)  ·  VA Office of Research and Development (1)  ·  Virginia Commonwealth University (1)

Countries

United States (9)  ·  Canada (2)  ·  Egypt (2)  ·  Kazakhstan (1)  ·  Russia (1)

Top investigators

Alexander V Savello, Prof (1)  ·  Andrew W Howard, MD, MSc (1)  ·  James Burch (1)  ·  Jose M. Garcia, MD PhD (1)  ·  Karen M Barlow, MB.ChB (1)  ·  Mitchell Scheiman, OD, PhD (1)  ·  Nancy Temkin, Ph.D. (1)  ·  Paul G Harch, MD (1)  ·  Randall J Urban, MD (1)  ·  Sara Gould, MD (1)  ·  Sylvia Lucas, MD, PhD (1)  ·  Taras A Skoromets, Prof (1)

Results publications

PMID 17166799, PMID 32189664, PMID 32217739, PMID 32772826, PMID 38894576, PMID 41551305

NIH funding

2018 (1)